Healthcare Stocks

PanGenomic Health Announces Intention To Dual List On The UK Aquis Stock Exchange Growth Market

  • January 31, 2023 09:15 AM EST | Reuters
 PanGenomic Health Announces Intention To Dual List On The UK Aquis Stock Exchange Growth Market

Jan 31 (Reuters) - Pangenomic Health Inc: * PANGENOMIC HEALTH ANNOUNCES INTENTION TO DUAL LIST ON THE UK AQUIS STOCK EXCHANGE GROWTH MARKET Source text for Eikon: Further company coverage:

Read More...

ESSA Pharma Inc expected to post a loss of 23 cents a share - Earnings Preview

ESSA Pharma Inc expected to post a loss of 23 cents a share - Earnings Preview

  • January 30, 2023 07:43 AM EST | Reuters

* ESSA Pharma Inc is expected to show no change in quarterly revenue when it reports results on February 1 (estimated). * * ​Refinitiv's mean analyst estimate for ESSA Pharma Inc is for a loss of 23

Read More...
ESSA Pharma Inc <EPIX.O>: A loss of 23 cents per share anticipated for fourth quarter

ESSA Pharma Inc <EPIX.O>: A loss of 23 cents per share anticipated for fourth quarter

  • January 30, 2023 07:42 AM EST | Reuters

30 January 2023 12:42 p.m. All figures in US dollars. ESSA Pharma Inc is expected to show a decrease in its fourth quarter earnings to -23 cents​ per share according to the mean Refinitiv estimate

Read More...
Microbix Launches QAP To Support “Monkeypox” Testing

Microbix Launches QAP To Support “Monkeypox” Testing

  • January 30, 2023 07:40 AM EST | Reuters

Jan 30 (Reuters) - Microbix Biosystems Inc: * MICROBIX LAUNCHES QAP TO SUPPORT “MONKEYPOX” TESTING Source text for Eikon: Further company coverage:

Read More...
Mikra Commences Commercial Scale Production Of Upgraded CELLF

Mikra Commences Commercial Scale Production Of Upgraded CELLF

  • January 30, 2023 07:32 AM EST | Reuters

Jan 30 (Reuters) - Lifeist Wellness Inc: * MIKRA COMMENCES COMMERCIAL SCALE PRODUCTION OF UPGRADED CELLF Source text for Eikon: Further company coverage:

Read More...
Aptose Starts Dosing Of Tuspetinib In Patients With Acute Myeloid Leukemia

Aptose Starts Dosing Of Tuspetinib In Patients With Acute Myeloid Leukemia

  • January 30, 2023 07:30 AM EST | Reuters

Jan 30 (Reuters) - Aptose Biosciences Inc: * APTOSE INITIATES DOSING OF TUSPETINIB IN APTIVATE EXPANSION TRIAL IN PATIENTS WITH ACUTE MYELOID LEUKEMIA * APTOSE BIOSCIENCES INC-ANOTHER CLINICAL

Read More...
Flora Growth Issues 2023 Revenue Guidance Of $90 Mln To $105 Mln

Flora Growth Issues 2023 Revenue Guidance Of $90 Mln To $105 Mln

  • January 30, 2023 07:23 AM EST | Reuters

Jan 30 (Reuters) - Flora Growth Corp: * FLORA GROWTH ISSUES 2023 REVENUE GUIDANCE OF $90 MILLION TO $105 MILLION REFLECTING ANTICIPATED YEAR OVER YEAR GROWTH EXCEEDING 100% * FLORA GROWTH CORP SEES FY

Read More...
XORTX Therapeutics Files For Mixed Shelf Of Up To $50 Mln

XORTX Therapeutics Files For Mixed Shelf Of Up To $50 Mln

  • January 27, 2023 07:01 AM EST | Reuters

Jan 27 (Reuters) - XORTX Therapeutics Inc: * XORTX THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING Further company coverage:

Read More...
Liminal Biosciences Announces Reverse Stock Split

Liminal Biosciences Announces Reverse Stock Split

  • January 26, 2023 05:35 PM EST | Reuters

Jan 26 (Reuters) - Liminal BioSciences Inc: * LIMINAL BIOSCIENCES ANNOUNCES REVERSE STOCK SPLIT * LIMINAL - CONSOLIDATION COMMON SHARES OF ON BASIS OF CONSOLIDATION RATIO OF TEN (10) PRE-CONSOLIDATION

Read More...
What to Watch in the Day Ahead - Friday, January 27

What to Watch in the Day Ahead - Friday, January 27

  • January 26, 2023 02:30 PM EST | Reuters

(The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at . Thomson One users

Read More...
U.S. FDA calls for new regulatory framework for use of cannabis compound CBD

U.S. FDA calls for new regulatory framework for use of cannabis compound CBD

  • January 26, 2023 01:37 PM EST | Reuters

(Reuters) - The U.S. Food and Drug Administration said on Thursday it does not intend to make any new guidance on the use of the popular cannabis compound CBD in food and supplements, saying the

Read More...

Frequently Asked Questions

There are multiple ways to look at any stock. It may include looking at fundamentals like dividends, earnings over the last few years, and ratios like price-to-earnings (P/E). The other way might be to look at what the future may hold. In the event of a large-scale demand in the future for a particular drug or vaccine that a company has produced or is likely to produce in the near term, the company's stock may find more backers. A look at what the company provides in the market, which can include hospital services, might be a good way to look at healthcare stocks.

There is a variety of choices available to the investor. Stocks represent companies that operate in sectors like healthcare, oil and gas, cannabis, and the list is long. The best stocks may relate to a particular industry, for example, the clean energy sector which has participants like Brookfield Renewable Partners, and Northland Power, or they can be a diversified mix of clean energy stocks and other sectors like oil and energy. In order to pick the best, the investor must study a little about the near-term market prospects for the related sector.

Considering the market environment at the time of writing this, Verde Agritech PLC (TSX: NPK) appears to be one of the fastest-growing stocks in Canada, with a price-to-earnings (P/E) ratio of 114.3. This crop nutrition and input stock has zoomed by over 450 per cent in the last 12 months. On the financial front, Verde Agritech expanded its 2021 net profit by 540 per cent year-on-year (YoY), and it expects 2022 revenue to reach C$ 72.26 million. However, investors should note that a stock’s performance can change depending on market conditions.

Healthcare stocks represent entities that provide arguably one of the most basic necessities to the wider world. They become even more crucial at the time of a pandemic or a large-scale disease outbreak in any particular region. Healthcare remains a growing sector as cures for all diseases have yet to be identified, and new ones like Covid-19 can crop up at any time. This makes healthcare stocks an interesting watch for a lot of investors.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK